In the latest episode of ‘COVID Watch’, Newsclick’s Prabir Purkayastha and immunologist Dr. Satyajit Rath discuss Covavax, the protein subunit-based vaccine manufactured by the US manufacturer Novavax. They talk about how it could address some of the challenges that the currently available vaccines are facing, such as cold storage, difficulty in scaling up production, etc. They also discuss how having multiple vaccines is better than using a single one across the globe.
Could Novavax’s COVID vaccine address some challenges in the current vaccination process?
Newsclick’s Prabir Purkayastha and immunologist Dr. Satyajit Rath discuss Covavax, the protein subunit-based vaccine manufactured by the US manufacturer Novavax
